Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akiko Nakai

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The Journal of Allergy and Clinical Immunology|March 10, 2018
Immune modulation by neuronal electric shock wavesKazuhiro Suzuki, Akiko Nakai
Neurochemistry International|October 22, 2018
Adrenergic control of lymphocyte trafficking and adaptive immune responsesAkiko Nakai, Kazuhiro Suzuki
International Immunology|April 4, 2024
Chemoattractant receptor signaling in humoral immunityTaiichiro Shirai, Akiko Nakai, Kazuhiro Suzuki
International Immunology|March 22, 2021
Control of immune cell trafficking through inter-organ communicationAkiko Nakai, Sarah Leach, Kazuhiro Suzuki
The Journal of Experimental Medicine|November 2, 2016
Adrenergic control of the adaptive immune response by diurnal lymphocyte recirculation through lymph nodesKazuhiro Suzuki, Yuki Hayano, Akiko Nakai, et al.
The Journal of Experimental Medicine|November 26, 2014
Control of lymphocyte egress from lymph nodes through β2-adrenergic receptorsAkiko Nakai, Yuki Hayano, Fumika Furuta, et al.
The Journal of Experimental Medicine|May 16, 2019
The COMMD3/8 complex determines GRK6 specificity for chemoattractant receptorsAkiko Nakai, Jun Fujimoto, Haruhiko Miyata, et al.
Kidney International|September 13, 2003
Selective protection of renal tubular epithelial cells by heme oxygenase (HO)-1 during stress-induced injuryYonghong Yang, Kazuhide Ohta, Masaki Shimizu, et al.
Pediatric Research|September 29, 2005
Glomerular proteinuria induces heme oxygenase-1 gene expression within renal epithelial cellsMasaki Shimizu, Kazuhide Ohta, Yonghong Yang, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 13, 2006
Rituximab therapy for Epstein-Barr virus-related chronic hepatitis following living donor kidney transplantationKazuhide Ohta, Masaki Shimizu, Akiko Nakai, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The Journal of Allergy and Clinical Immunology|March 10, 2018
Immune modulation by neuronal electric shock wavesKazuhiro Suzuki, Akiko Nakai
Neurochemistry International|October 22, 2018
Adrenergic control of lymphocyte trafficking and adaptive immune responsesAkiko Nakai, Kazuhiro Suzuki
International Immunology|April 4, 2024
Chemoattractant receptor signaling in humoral immunityTaiichiro Shirai, Akiko Nakai, Kazuhiro Suzuki
International Immunology|March 22, 2021
Control of immune cell trafficking through inter-organ communicationAkiko Nakai, Sarah Leach, Kazuhiro Suzuki
The Journal of Experimental Medicine|November 2, 2016
Adrenergic control of the adaptive immune response by diurnal lymphocyte recirculation through lymph nodesKazuhiro Suzuki, Yuki Hayano, Akiko Nakai, et al.
The Journal of Experimental Medicine|November 26, 2014
Control of lymphocyte egress from lymph nodes through β2-adrenergic receptorsAkiko Nakai, Yuki Hayano, Fumika Furuta, et al.
The Journal of Experimental Medicine|May 16, 2019
The COMMD3/8 complex determines GRK6 specificity for chemoattractant receptorsAkiko Nakai, Jun Fujimoto, Haruhiko Miyata, et al.
Kidney International|September 13, 2003
Selective protection of renal tubular epithelial cells by heme oxygenase (HO)-1 during stress-induced injuryYonghong Yang, Kazuhide Ohta, Masaki Shimizu, et al.
Pediatric Research|September 29, 2005
Glomerular proteinuria induces heme oxygenase-1 gene expression within renal epithelial cellsMasaki Shimizu, Kazuhide Ohta, Yonghong Yang, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 13, 2006
Rituximab therapy for Epstein-Barr virus-related chronic hepatitis following living donor kidney transplantationKazuhide Ohta, Masaki Shimizu, Akiko Nakai, et al.
Pageof 2